381 related articles for article (PubMed ID: 7891251)
1. Immunoglobulin isotypes in gingival crevicular fluid: possible protective role of IgA.
Grbic JT; Singer RE; Jans HH; Celenti RS; Lamster IB
J Periodontol; 1995 Jan; 66(1):55-61. PubMed ID: 7891251
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory and immune mediators in crevicular fluid from HIV-infected injecting drug users.
Grbic JT; Lamster IB; Mitchell-Lewis D
J Periodontol; 1997 Mar; 68(3):249-55. PubMed ID: 9100200
[TBL] [Abstract][Full Text] [Related]
3. Changes in gingival crevicular fluid levels of immunoglobulin A following therapy: association with attachment loss.
Grbic JT; Lamster IB; Fine JB; Lam KS; Celenti RS; Herrera-Abreu M; Singer RE
J Periodontol; 1999 Oct; 70(10):1221-7. PubMed ID: 10534077
[TBL] [Abstract][Full Text] [Related]
4. Development of a risk profile for periodontal disease: microbial and host response factors.
Lamster IB; Smith QT; Celenti RS; Singer RE; Grbic JT
J Periodontol; 1994 May; 65(5 Suppl):511-20. PubMed ID: 8046567
[TBL] [Abstract][Full Text] [Related]
5. The association between gingival crevicular fluid TGF-beta1 levels and periodontal status in HIV-1(+) patients.
Alpagot T; Konopka K; Bhattacharyya M; Gebremedhin S; Düzgüneş N
J Periodontol; 2008 Jan; 79(1):123-30. PubMed ID: 18166101
[TBL] [Abstract][Full Text] [Related]
6. Correlation of gingival crevicular fluid interleukin-18 and monocyte chemoattractant protein-1 levels in periodontal health and disease.
Pradeep AR; Daisy H; Hadge P; Garg G; Thorat M
J Periodontol; 2009 Sep; 80(9):1454-61. PubMed ID: 19722796
[TBL] [Abstract][Full Text] [Related]
7. Soluble CD14 levels in gingival crevicular fluid of subjects with untreated adult periodontitis.
Jin L; Darveau RP
J Periodontol; 2001 May; 72(5):634-40. PubMed ID: 11394399
[TBL] [Abstract][Full Text] [Related]
8. Origin of galactose-deficient immunoglobulin g in gingival crevicular fluid in periodontitis.
Komiyama Y; Kafkova LR; Barasch A; Shah GR; Grbic JT; Novak Z; Komiyama K; Novak J; Mestecky J; Moldoveanu Z
J Periodontol; 2014 Dec; 85(12):1779-85. PubMed ID: 25152004
[TBL] [Abstract][Full Text] [Related]
9. Use of a fluorogenic septapeptide matrix metalloproteinase assay to assess responses to periodontal treatment.
Bhide VM; Smith L; Overall CM; Birek P; McCulloch CA
J Periodontol; 2000 May; 71(5):690-700. PubMed ID: 10872948
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1 beta, prostaglandin E2, and immunoglobulin G subclasses in gingival crevicular fluid in patients undergoing periodontal therapy.
Alexander DC; Martin JC; King PJ; Powell JR; Caves J; Cohen ME
J Periodontol; 1996 Aug; 67(8):755-62. PubMed ID: 8866314
[TBL] [Abstract][Full Text] [Related]
11. Gingival crevicular fluid levels of monocyte chemoattractant protein-1 in periodontal health and disease.
Pradeep AR; Daisy H; Hadge P
Arch Oral Biol; 2009 May; 54(5):503-9. PubMed ID: 19286166
[TBL] [Abstract][Full Text] [Related]
12. The relationship of beta-glucuronidase activity in crevicular fluid to clinical parameters of periodontal disease. Findings from a multicenter study.
Lamster IB; Holmes LG; Gross KB; Oshrain RL; Cohen DW; Rose LF; Peters LM; Pope MR
J Clin Periodontol; 1994 Feb; 21(2):118-27. PubMed ID: 8144731
[TBL] [Abstract][Full Text] [Related]
13. Adjunctive subantimicrobial dose doxycycline: effect on clinical parameters and gingival crevicular fluid transforming growth factor-beta levels in severe, generalized chronic periodontitis.
Gürkan A; Cinarcik S; Hüseyinov A
J Clin Periodontol; 2005 Mar; 32(3):244-53. PubMed ID: 15766366
[TBL] [Abstract][Full Text] [Related]
14. Analysis of human gingival tissue and gingival crevicular fluid beta-glucuronidase activity in specific periodontal diseases.
Layik M; Yamalik N; Caglayan F; Kilinç K; Etikan I; Eratalay K
J Periodontol; 2000 Apr; 71(4):618-24. PubMed ID: 10807127
[TBL] [Abstract][Full Text] [Related]
15. Gingival crevicular fluid alkaline phosphatase levels in postmenopausal women: effects of phase I periodontal treatment.
Daltaban O; Saygun I; Bal B; Baloş K; Serdar M
J Periodontol; 2006 Jan; 77(1):67-72. PubMed ID: 16579705
[TBL] [Abstract][Full Text] [Related]
16. Beta-glucuronidase activity in saliva: relationship to clinical periodontal parameters.
Lamster IB; Kaufman E; Grbic JT; Winston LJ; Singer RE
J Periodontol; 2003 Mar; 74(3):353-9. PubMed ID: 12710755
[TBL] [Abstract][Full Text] [Related]
17. Gingival crevicular fluid alkaline phosphatase activity reflects periodontal healing/recurrent inflammation phases in chronic periodontitis patients.
Perinetti G; Paolantonio M; Femminella B; Serra E; Spoto G
J Periodontol; 2008 Jul; 79(7):1200-7. PubMed ID: 18597602
[TBL] [Abstract][Full Text] [Related]
18. Serum and gingival fluid antibodies as adjuncts in the diagnosis of Actinobacillus actinomycetemcomitans-associated periodontal disease.
Genco RJ; Zambon JJ; Murray PA
J Periodontol; 1985 Nov; 56(11 Suppl):41-50. PubMed ID: 3908639
[TBL] [Abstract][Full Text] [Related]
19. Effects of phase I periodontal treatment on gingival crevicular fluid levels of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1.
Tüter G; Kurtiş B; Serdar M
J Periodontol; 2002 May; 73(5):487-93. PubMed ID: 12027249
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-8 and beta-glucuronidase in gingival crevicular fluid.
Chung RM; Grbíc JT; Lamster IB
J Clin Periodontol; 1997 Mar; 24(3):146-52. PubMed ID: 9083897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
